Lawrence A Kenyon Outlook Therapeutics, Inc. (OTLK) insider trading activity
Lawrence A Kenyon is CHIEF FINANCIAL OFFICER of Outlook Therapeutics, Inc.. Currently has a direct ownership of 18,926 shares of OTLK, which is worth approximately $134,185. The most recent transaction as insider was on Apr 20, 2021, when has been sold 10,000 shares (Common Stock) at a price of $1.83 per share, resulting in proceeds of $18,300. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
18.9K
0%
3M change
0%
12M change
Total Value Held
$134,185
LAK
Lawrence A Kenyon
CHIEF FINANCIAL OFFICER
Monmouth Junction, NJ